Indications and Purposes
| 1 Indications And Usage Yonsa Is Indicated In Combination With Methylprednisolone For The Treatment Of Patients With Metastatic Castration-Resistant Prostate Cancer. Yonsa Is A Cyp17 Inhibitor Indicated In Combination With Methylprednisolone For The Treatment Of Patients With Metastatic Castration-Resistant Prostate Cancer (Crpc). (1) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Abiraterone Acetate |
|
ZINC5224164 |